In Epm2b-/- mice, we observed a significant improvement after the treatment with FGD (P < 0.01) and DMF (P < 0.0001) in comparison to the untreated Epm2b-/- mice (Fig. 3). Here, NHLRC1 is linked to Aarskog-Scott syndrome, X-linked.